Clinical Trials in Los Angeles

Showing 10361-10380 of 14,465 trials

Enhancing Housing First Programs With a Social Network Substance Use Intervention

NCT02140359

Housing First programs are promising approaches to transitioning substance using chronically homeless adults to affordable housing. However, Housing First programs need to provide support to residents to adjust to their changing social environments. The proposed project fulfills a critical gap by developing an electronic tool for a social network intervention using motivational interviewing techniques as well as results of a pilot test of the tool. The hypothesis to be tested is that Housing First residents who are given the intervention will be significantly more motivated to change their drinking, drug use, sexual risk behaviors, and social networks compared to controls receiving usual care.

Alcohol DrinkingDrug AbuseHIV

RAND50 participantsStarted Jun 2015

Los Angeles, California, United States • Santa Monica, California, United States

COMPLETEDPhase 2< 1 mile

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

NCT01023958

The primary objective of this trial is to evaluate the efficacy and safety of BI 6727 in patients with locally advanced, metastatic or recurrent urothelial cancer after failure of first line or adjuvant/neoadjuvant chemotherapy.

Neoplasms

Boehringer Ingelheim50 participantsStarted Nov 2009

Beverly Hills, California, United States • Los Angeles, California, United States • Miami, Florida, United States +18 more locations

Enhancing Housing First Programs With a Social Network Substance Use Intervention

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Find Trials by Condition in Los Angeles

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Safety Escalating Repeat IV, in Stroke Patients

Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Proof of Concept (POC) in Patients With Ischaemic Stroke

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Clinical Evaluation of Patients With X-linked Retinoschisis